How many is too many? Polyposis syndromes and what to do next.

Nina Gupta, Christine Drogan, Sonia S Kupfer
Author Information
  1. Nina Gupta: Section of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Chicago, Chicago, Illinois, USA.

Abstract

PURPOSE OF REVIEW: The goal of this review is to help providers recognize, diagnose and manage gastrointestinal (GI) polyposis syndromes.
RECENT FINDINGS: Intestinal polyps include a number of histological sub-types such as adenomas, serrated, hamartomas among others. Over a quarter of individuals undergoing screening colonoscopy are expected to have colonic adenomas. Although it is not uncommon for adults to have a few GI polyps in their lifetime, some individuals are found to have multiple polyps of varying histology throughout the GI tract. In these individuals, depending on polyp histology, number, location and size as well as extra-intestinal features and/or family history, a polyposis syndrome should be considered with appropriate testing and management.
SUMMARY: Diagnosis and management of polyposis syndromes has evolved with advent of multigene panel testing and new data on optimal surveillance strategies. Evidence-based recommendations and current practice guidelines for polyposis syndromes are reviewed here. Areas of uncertainty and future research are also highlighted.

References

  1. J Clin Med. 2021 Jan 27;10(3): [PMID: 33513864]
  2. Gut. 2008 Jan;57(1):71-6 [PMID: 17604324]
  3. Clin Colon Rectal Surg. 2008 Nov;21(4):263-72 [PMID: 20011437]
  4. Hum Mutat. 2019 Nov;40(11):1910-1923 [PMID: 31243857]
  5. Am J Med Genet A. 2011 Apr;155A(4):898-902 [PMID: 21416598]
  6. J Clin Oncol. 2005 Aug 20;23(24):5651-9 [PMID: 16110024]
  7. Mol Genet Genomic Med. 2019 Apr;7(4):e00603 [PMID: 30827058]
  8. Sci Rep. 2019 Jul 8;9(1):9814 [PMID: 31285513]
  9. Cancer Prev Res (Phila). 2020 Mar;13(3):291-298 [PMID: 32051178]
  10. Gastroenterology. 2020 Apr;158(5):1326-1333 [PMID: 31926173]
  11. JAMA. 2016 Mar 22-29;315(12):1266-75 [PMID: 27002448]
  12. Fam Cancer. 2017 Apr;16(2):195-203 [PMID: 27696107]
  13. Genet Med. 2019 Aug;21(8):1868-1873 [PMID: 30573798]
  14. JCO Precis Oncol. 2021 Feb 26;5: [PMID: 34250384]
  15. Nat Genet. 2013 Feb;45(2):136-44 [PMID: 23263490]
  16. Hum Mutat. 2007 Oct;28(10):985-92 [PMID: 17486639]
  17. Gut. 2016 Nov;65(11):1829-1837 [PMID: 26264224]
  18. Gut. 2020 Jan;69(1):112-121 [PMID: 30981990]
  19. Clin Genet. 2018 Dec;94(6):588-589 [PMID: 30248171]
  20. Genet Med. 2020 Sep;22(9):1524-1532 [PMID: 32398773]
  21. Gut. 2017 Jun;66(6):1170-1172 [PMID: 27582512]
  22. Eur J Hum Genet. 2015 Aug;23(8):1080-4 [PMID: 25370038]
  23. Nat Genet. 2012 May 06;44(6):699-703 [PMID: 22561515]
  24. Clin Gastroenterol Hepatol. 2014 Jun;12(6):1046-50 [PMID: 24362051]
  25. Clin Genet. 2021 Feb;99(2):219-225 [PMID: 33140411]
  26. Sci Rep. 2017 May 22;7(1):2214 [PMID: 28533537]
  27. Am J Hum Genet. 2016 Aug 4;99(2):337-51 [PMID: 27476653]
  28. Cancer Prev Res (Phila). 2021 Mar;14(3):325-336 [PMID: 33277315]
  29. Fam Cancer. 2020 Jul;19(3):223-239 [PMID: 32172433]
  30. N Engl J Med. 2015 Nov 12;373(20):1985-6 [PMID: 26559593]
  31. Fam Cancer. 2019 Jan;18(1):63-66 [PMID: 29804199]
  32. Clin Gastroenterol Hepatol. 2017 Mar;15(3):461-462 [PMID: 27720914]
  33. Gut. 2017 Jul;66(7):1225-1232 [PMID: 26911398]
  34. Fam Cancer. 2017 Jul;16(3):371-376 [PMID: 28185118]
  35. Nat Genet. 2015 Jun;47(6):668-71 [PMID: 25938944]
  36. Fam Cancer. 2019 Apr;18(2):179-182 [PMID: 30859360]
  37. Gastrointest Endosc. 2018 Oct;88(4):726-733 [PMID: 29864420]
  38. Gut. 2017 Sep;66(9):1645-1656 [PMID: 27329244]
  39. Gastroenterology. 2012 Sep;143(3):844-857 [PMID: 22763141]
  40. Gastroenterology. 2009 Apr;136(4):1251-60 [PMID: 19245865]
  41. Cancer Res. 2003 Apr 15;63(8):1894-9 [PMID: 12702580]
  42. Mayo Clin Proc. 2019 Jun;94(6):1099-1116 [PMID: 31171120]
  43. Int J Cancer. 2015 Jul 15;137(2):320-31 [PMID: 25529843]
  44. JAMA Oncol. 2018 May 1;4(5):671-677 [PMID: 29423501]
  45. Histopathology. 2021 Apr;78(5):749-758 [PMID: 33098683]
  46. NPJ Breast Cancer. 2021 May 12;7(1):52 [PMID: 33980861]
  47. Genet Med. 2020 Sep;22(9):1533-1541 [PMID: 32424176]
  48. Sci Rep. 2019 Jun 21;9(1):9020 [PMID: 31227763]
  49. Am J Hum Genet. 2004 May;74(5):1043-50 [PMID: 15042511]
  50. Genet Res (Camb). 2015 May 20;97:e11 [PMID: 25992589]
  51. Genet Med. 2016 Apr;18(4):325-32 [PMID: 26133394]
  52. Hum Pathol. 2017 Feb;60:75-81 [PMID: 27984123]
  53. Hum Mutat. 2006 Oct;27(10):1064 [PMID: 16941501]
  54. Mol Genet Genomic Med. 2020 Nov;8(11):e1493 [PMID: 32949222]
  55. J Hum Genet. 2019 Aug;64(8):729-740 [PMID: 31089268]
  56. Gut. 2004 Mar;53(3):381-6 [PMID: 14960520]
  57. J Pathol. 2018 Feb;244(2):135-142 [PMID: 29105096]
  58. Genet Med. 2020 Dec;22(12):2089-2100 [PMID: 32792570]
  59. Gut. 2017 Feb;66(2):278-284 [PMID: 26603485]
  60. J Clin Gastroenterol. 2022 Mar 1;56(3):e183-e188 [PMID: 34231499]
  61. J Natl Compr Canc Netw. 2019 Sep 1;17(9):1032-1041 [PMID: 31487681]
  62. Gastroenterology. 2017 Jun;152(8):1876-1880.e1 [PMID: 28242209]
  63. Genet Res (Camb). 2016 Mar 07;98:e5 [PMID: 26947005]
  64. Dis Colon Rectum. 2014 Mar;57(3):396-7 [PMID: 24509466]
  65. Genes Chromosomes Cancer. 2016 Jan;55(1):95-106 [PMID: 26493165]
  66. BMC Med Genet. 2020 Aug 17;21(1):161 [PMID: 32807118]
  67. Clin Gastroenterol Hepatol. 2020 Apr;18(4):777-779 [PMID: 31520728]
  68. Oncotarget. 2015 Oct 27;6(33):34069-70 [PMID: 26431160]
  69. Hum Mutat. 2005 May;25(5):498-500 [PMID: 15841489]
  70. Am J Gastroenterol. 2016 Feb;111(2):275-84 [PMID: 26729549]
  71. Gastrointest Endosc. 2019 May;89(5):961-968 [PMID: 30597145]
  72. Fam Cancer. 2017 Jan;16(1):67-71 [PMID: 27573199]
  73. Hum Mol Genet. 2014 Jul 1;23(13):3506-12 [PMID: 24501277]
  74. Fam Cancer. 2019 Jul;18(3):311-315 [PMID: 30671715]
  75. Genet Med. 2018 Aug;20(8):890-895 [PMID: 29120461]
  76. Cancer Cell. 2019 Feb 11;35(2):256-266.e5 [PMID: 30753826]
  77. Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263 [PMID: 25645574]
  78. Gut. 2008 May;57(5):704-13 [PMID: 18194984]
  79. Gastrointest Endosc. 2020 May;91(5):963-982.e2 [PMID: 32169282]
  80. Gastroenterol Hepatol (N Y). 2019 Sep;15(9):462-470 [PMID: 31787853]
  81. Clin Gastroenterol Hepatol. 2019 Sep;17(10):2008-2015.e3 [PMID: 30557735]
  82. Gastroenterology. 2010 Jun;138(6):2044-58 [PMID: 20420945]
  83. Fam Cancer. 2022 Apr;21(2):197-209 [PMID: 33948826]
  84. Fam Cancer. 2021 Jan;20(1):23-33 [PMID: 32507936]
  85. Hum Mutat. 1994;3(2):121-5 [PMID: 8199592]
  86. Gastroenterology. 2014 May;146(5):1208-11.e1-5 [PMID: 24444654]
  87. Gastroenterology. 2021 Feb;160(3):952-954.e4 [PMID: 33130102]
  88. Hum Genome Var. 2019 Oct 10;6:46 [PMID: 31645984]
  89. Oncotarget. 2017 Apr 18;8(16):26732-26743 [PMID: 28423643]
  90. Hered Cancer Clin Pract. 2020 Jul 30;18:14 [PMID: 32754288]
  91. Gastrointest Endosc. 2020 Nov;92(5):1098-1107.e1 [PMID: 32360902]
  92. Eur J Hum Genet. 2014 Mar;22(3):423-6 [PMID: 23838596]

Grants

  1. P30 DK042086/NIDDK NIH HHS
  2. R01 CA220329/NCI NIH HHS

MeSH Term

Adenoma
Adult
Colonic Polyps
Colonoscopy
Colorectal Neoplasms
Humans
Intestinal Polyps
Peutz-Jeghers Syndrome

Word Cloud

Created with Highcharts 10.0.0polyposissyndromesGIpolypsindividualsnumberadenomashistologytestingmanagementPURPOSEOFREVIEW:goalreviewhelpprovidersrecognizediagnosemanagegastrointestinalRECENTFINDINGS:Intestinalincludehistologicalsub-typesserratedhamartomasamongothersquarterundergoingscreeningcolonoscopyexpectedcolonicAlthoughuncommonadultslifetimefoundmultiplevaryingthroughouttractdependingpolyplocationsizewellextra-intestinalfeaturesand/orfamilyhistorysyndromeconsideredappropriateSUMMARY:DiagnosisevolvedadventmultigenepanelnewdataoptimalsurveillancestrategiesEvidence-basedrecommendationscurrentpracticeguidelinesreviewedAreasuncertaintyfutureresearchalsohighlightedmanymany?Polyposisnext

Similar Articles

Cited By